144 related articles for article (PubMed ID: 36354295)
1. Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression.
Xiang H; Liu C; Xiao Z; Du L; Wei N; Liu F; Song Y
Liver Int; 2023 Mar; 43(3):626-638. PubMed ID: 36354295
[TBL] [Abstract][Full Text] [Related]
2. Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome.
Liu Z; Liang S; Wei X; Du X; Zhang J
BMC Gastroenterol; 2022 Dec; 22(1):525. PubMed ID: 36526956
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.
Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y
BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.
Yang XQ; Ye J; Li X; Li Q; Song YH
World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770
[TBL] [Abstract][Full Text] [Related]
5. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.
Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY
Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783
[TBL] [Abstract][Full Text] [Related]
6. Liver Inflammatory Injury Initiated by DAMPs-TLR4-MyD88/TRIF-NFκB Signaling Pathway Is Involved in Monocrotaline-Induced HSOS.
Huang Z; Chen M; Wei M; Lu B; Wu X; Wang Z; Ji L
Toxicol Sci; 2019 Dec; 172(2):385-397. PubMed ID: 31504964
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
Jiang M; Wang L; Du X; Hao M; Gao P
J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury.
Huang Z; Jing X; Sheng Y; Zhang J; Hao Z; Wang Z; Ji L
Redox Biol; 2019 Apr; 22():101117. PubMed ID: 30822691
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide attenuated MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and antioxidant response.
Huang Z; Wu Z; Zhang J; Wang K; Zhao Q; Chen M; Yan S; Guo Q; Ma Y; Ji L
Cell Biol Toxicol; 2023 Dec; 39(6):3269-3285. PubMed ID: 37816928
[TBL] [Abstract][Full Text] [Related]
10. Liquiritigenin and liquiritin alleviated monocrotaline-induced hepatic sinusoidal obstruction syndrome via inhibiting HSP60-induced inflammatory injury.
Huang Z; Zhao Q; Chen M; Zhang J; Ji L
Toxicology; 2019 Dec; 428():152307. PubMed ID: 31589899
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome.
Shang H; Huang C; Xiao Z; Yang P; Zhang S; Hou X; Zhang L
Cell Biosci; 2023 Jul; 13(1):127. PubMed ID: 37422682
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.
Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X
Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study.
Peng C; Zhang X; Zhang F; Liu L; Shao Y; Xiang X; Zhang W; Xiao J; Wang Y; Zhang B; Yin Q; Song Y; Mo Z; Zou X; Zhang M; Zhuge Y
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1168-1178. PubMed ID: 31834055
[TBL] [Abstract][Full Text] [Related]
14. Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system.
Huang Z; Sheng Y; Chen M; Hao Z; Hu F; Ji L
Toxicol Appl Pharmacol; 2018 Sep; 355():18-27. PubMed ID: 29908794
[TBL] [Abstract][Full Text] [Related]
15. Tusanqi and hepatic sinusoidal obstruction syndrome.
Wang JY; Gao H
J Dig Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24528632
[TBL] [Abstract][Full Text] [Related]
16. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.
Guo T; Li X; Yang X; Kong X; Liu H; Bai T; Xu K; Ye J; Song Y
Sci Rep; 2019 Feb; 9(1):1231. PubMed ID: 30718698
[TBL] [Abstract][Full Text] [Related]
18. Bear bile powder attenuates senecionine-induced hepatic sinusoidal obstruction syndrome in mice.
Jiang KY; Zhang Y; Ye XL; Xiong F; Chen Y; Jia XL; Zhang YX; Yang L; Xiong AZ; Wang ZT
Chin J Nat Med; 2022 Apr; 20(4):270-281. PubMed ID: 35487597
[TBL] [Abstract][Full Text] [Related]
19. Rifaximin Prevents Intestinal Barrier Dysfunction and Alleviates Liver Injury in MCT-induced HSOS Mice.
Shu YY; Hu LL; Yang L; Chu HK; Ye J; Jin Y
Curr Med Sci; 2023 Dec; 43(6):1183-1194. PubMed ID: 37950130
[TBL] [Abstract][Full Text] [Related]
20. Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3.
Ren X; Xu K; Xu J; Mei Q
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23422. PubMed ID: 37350538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
